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Abstract 
The Joint United Nations Programme on HIV and AIDS (UNAIDS) has embraced an ambitious global target for the 
implementation of treatment for people living with HIV. This 90-90-90 target would mean that, by 2020, 90% of all those 
living with HIV should know their status, 90% of these would be on treatment and 90% of these would have fully suppressed 
plasma viral loads. To reach this target in the next five years presents a major logistical challenge. However, the prevalence of 
HIV varies greatly by risk groups, age, gender, geography and social conditions. For reasons of equity no-one should be denied 
access to life-saving anti-retroviral therapy (ART) but for reasons of effectiveness and impact the focus must first be on those 
who are most likely to be infected with HIV and therefore most likely to infect others. 
 In Kenya the prevalence of HIV in adults varies by two orders of magnitude among the counties. The effective 
implementation of 90-90-90 will depend on first providing ART where the prevalence of infection is greatest, then to those that 
are most easily reached in large numbers and finally to the whole population. Here we use routine data from ante-natal clinics 
and national survey data to assess the variation of the prevalence of HIV among counties in Kenya; we suggest reasons for this 
variation, and estimate the effectiveness of targeting the role out of ART. 
 The highest prevalence occurs in some, but not all, of the counties bordering Lake Victoria and these are most in 
need of ART. These districts in Nyanza Province, account for 31% of all cases in Kenya even though they only make up 10% 
of the population and cover 1.8% of the land-area. The highest concentrations of HIV cases are in Nairobi and Mombasa. 
These two cities account for a further 18% of all cases in Kenya but only make up 12% of the population and cover 0.1% of 
the land-area. The logistics of providing ART in these two cities will be relatively straightforward given their small 
geographical area. Finally we note that Nakuru County, on the main highway from Mombasa to Nairobi and then to Uganda, 
has the next highest prevalence of HIV after the counties in Nyanza Province and the two major cities.  
  
Introduction 
It has become increasingly clear that when people are 
infected with HIV they should start anti-retroviral treatment 
(ART) as soon as possible; any delay in the start of 
treatment increases a persons risk of dying.1 Furthermore, 
with good treatment and adherence an infected persons’ 
viral load falls by a factor of 100 within one month and 
10,000 within 12 months2 rendering them uninfectious to 
other people. In the year 2000 the International AIDS 
Society3 and the Department of Health and Human 
Services4 recommended immediate ART for all HIV 
positive people if their CD4 cell count was below 500/μL5 
and this is now supported by the World Health 
Organization6 and others.7 
 The fact that early ART is not only in the best interest 
of the individual person infected with HIV but also has the 
potential to stop transmission has led the Joint United 
Nations Programme on HIV and AIDS (UNAIDS) to call 
for an end to HIV/AIDS centred on their 90-90-90 target: 
by 2020, 90% of all those living with HIV should have 
been tested within the last one year, unless of course they 
already know that they are infected with HIV, 90% of these 
should be on treatment and 90% of these should have 
plasma viral loads below 1,000 copies/mL. 
 Reaching the 90-90-90 target by 2020 is ambitious. It 
will require many things to be in place including a regular 
and assured supply of drugs, good community mobilization 
and support to counter stigma and discrimination, good 
counselling and support to ensure high levels of adherence 
and to promote safe sex, other methods of prevention, good 
patient monitoring and follow up to identify places where 
the programme may be failing, and good surveillance tools 
to know whether the targets are being reached. 
 Given these many challenges, as well as the need to 
mobilize funding and human resources, it will be essential 
to plan and implement the programme as efficiently and as 
cost effectively as possible. In this paper we use data from 
Kenya to examine, in particular, the geographical 
distribution of HIV infection to provide support for 
planning and implementing what will be one of the most 
challenging public health disease-control programmes ever 
attempted. 
 We start by carefully re-examining the available data on 
HIV in Kenya, largely derived from measurements of the 
prevalence of HIV in women attending ante-natal clinics 
(ANC) for each of the counties of Kenya. Since these are 
the only data on epidemic trends in Kenya, as in most other 
countries in Africa, it is essential that these data are 
reviewed very carefully. 
 Having fitted trends to the available data we consider 
the counties in three groups: Nyanza Province,* where the 
prevalence is highest, Nairobi and Mombasa, where the 
density of infected people is greatest, and the remaining 
counties, where both the prevalence of infection and the 
density of infected people is relatively low. 
 Finally, we consider some explanations for the 
geographical diversity of the epidemic in Kenya and 
discuss the implications for achieving the 90-90-90 target 
by 2020. 
                                                          
*  Nyanza Province contains Siaya, Kisumu, Homa Bay and Migori 
Counties 
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Figure 1. Kenya County names as of 2014. 
Methods 
Figure 1 is a map of Kenya with the counties indicated for 
the purposes of the discussion that follows. We draw on 
two sets of data. The first gives the prevalence of HIV 
measured at different times in ANC clinics in each of the 
counties. These data are available from the ‘Spectrum’ files 
held by UNAIDS in Geneva.8 Unfortunately, these data 
were not collected consistently over time and according to 
rigorous standards, and there is considerable variation over 
and above the binomial errors which needs to be included. 
Fortunately, a large survey was carried out in 2006 in 
which 564,253 women attending ante-natal clinics were 
tested for HIV from all counties in Kenya9 and this 
provides a key marker that determines the prevalence of 
infection in each county. The geographical distribution of 
the prevalence of HIV in 2006 is given in Figure 2 where 
the upper part of the figure is for the whole country and the 
lower part shows a detailed distribution in Nyanza Province 
and the adjacent districts. 
 In all counties of Kenya the prevalence rose to a peak, 
fell significantly and then levelled off to an asymptote. To 
fit the data we therefore proceed as follows. We fit a 
double-logistic function to the available trend data for each 
county in Kenya so that the prevalence of infection at time t 
is 
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The first term in Equation 1 accounts for the rate, r1, the 
timing, t1, and the peak, a1, of the initial rise in the 
prevalence. The second term accounts for the rate, r2, the 
timing t2, and the subsequent drop, a2, in the prevalence as 
a result of reductions in transmission not apparently 
associated with the increasing coverage of ART. The 
reasons for, and drivers of, these reductions in transmission 
are not understood and we discuss this further below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. HIV prevalence among women attending ante-natal 
clinics in each district of Kenya in 2006. County names are given 
in Figure 1 and abbreviated here. Bondo District is now included 
in Siaya County, Nyanza District in Kisumu County, Rachuonyo 
and Suba districts in Homa Bay County, and Kuria district in 
Migori County. 
 We start with a conventional least squares fit to those 
counties with reasonably consistent data but with the 
proviso that the data points were scaled, in each county, by 
a factor, σ, chosen to ensure that the fitted curve passes 
exactly through the measured prevalence for that county in 
2006. This factor σ was allowed to vary in the optimization 
routine and is discussed further below. 
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Figure 3. HIV prevalence in ante-natal clinics in Kenya between 1980 and 2012. Blue dots: routine surveys. Red dots: 2006 survey. 
Green lines: Fitted curves, all with 95% confidence limits. 
 
 
P
re
va
le
nc
e 
   
   
 P
re
va
le
nc
e 
   
   
  P
re
va
le
nc
e 
   
   
 P
re
va
le
nc
e 
   
   
 P
re
va
le
nc
e 
   
   
 P
re
va
le
nc
e 
   
   
  P
re
va
le
nc
e 
   
   
  P
re
va
le
nc
e 
   
   
 P
re
va
le
nc
e 
   
   
 P
re
va
le
nc
e 
   
   
 P
re
va
le
nc
e 
   
   
  P
re
va
le
nc
e 
   
   
 4 
 For each of the parameters in Equation 1 we then 
calculate the mean and the standard deviation across all of 
the counties for which the data are reasonably consistent 
over several years and use the distributions of these 
parameters and the constraint on the scale factor, σ, as prior 
estimates in a Bayesian fit to the data. In Nyanza Province 
the peak prevalence greatly exceeded that in any other 
province, and in Nairobi and Mombassa, the epidemic 
started earlier than in other counties. We therefore used 
three different sets of prior distributions for Nyanza, 
Nairobi and Mombassa, and for the remaining counties. 
 When combining the data across districts we weighted 
the prevalence in each district by the 2014 estimates of the 
adult population in each district10 to calculate the overall 
prevalence. 
Results 
The 2006 survey is a critical reference year for the 
prevalence of HIV in Kenya.9 It shows clearly that in 2006 
the ANC prevalence of HIV varied from about 2% to 5% in 
most counties but ranged from 17% to 26% in Nyanza 
Province. It is interesting to note (Figure 2) that in Busia, 
which borders both Uganda and Lake Victoria, the 
prevalence of HIV was only 8%, about one-third of the 
prevalence in the other counties neighbouring Lake 
Victoria. We also see in Figure 2 that the prevalence in 
Mombasa, Nairobi and Nakuru was relatively high, at about 
15%, and note that these three towns are on the main 
highway from Mombasa to Uganda. 
 The fitted data, with 95% confidence limits on the data 
points and the fitted curves are given in Figure 3. The blue 
dots are the routine ANC data and one sees that they are 
very variable. The data for Busia, Embu, Nakuru and Trans 
Nzoia are reasonably consistent while the data for Isiolo, 
Lamu, Mandera, Narok and several other counties are 
limited. Nevertheless the combination of the ANC data, the 
results of the very extensive survey in 2006, and the use of 
Bayesian priors give reasonably convincing fits across the 
whole country (Figure 3). We also compare the 
distributions of the key parameters from the fits among the 
counties to ensure consistency and to understand 
differences in the epidemic in different counties. 
 For all three groups of counties the mean value of the 
scale parameter in the Appendix, Figure 6 is close to 1 
which is important since it suggests that, on average, the 
estimates from the 2006 survey are in agreement with the 
routine ANC data. There is, however, some variation about 
the mean, especially in the low prevalence group of 
countries. In Laikipia, for example, the routine ANC data 
have to be almost doubled to bring them up to the value 
obtained in the 2006 survey, while in Garissa and Taraka 
Nithi the routine data have to be reduced by a factor of 5. 
 In all three groups of counties the data in Figure 7 
suggest that the prevalence of HIV reached half the 
maximum value in about 1993 so that it seems that the 
epidemic took off at about the same time in all areas of the 
country but may have risen slightly earlier in Nairobi and 
Mombasa than in the rest of the country. One should note 
that in many of the low prevalence counties there was very 
little data to suggest when the initial rise occurred. In 
Figure 7 the Bayesian priors mean that a very similar value 
for the initial rise is obtained across all counties for which 
the early data are weak or absent. 
 The timing of the fall in prevalence (Appendix, Figure 
8), is also consistent across the three groups of counties and 
the decline reached half its value in 2000 although there is 
some variation among counties with some falling to half the 
final asymptote in 1996 and others only in 2006. On 
average it seems that the fall occurred about 7 years after 
the rise to the peak. 
 The initial rates of increase, 0.4/year (Figure 9), and 
decline, 0.9/year (Figure 10), are also similar across all 
counties but this also reflects the fact that few counties have 
good data on the initial rise in the prevalence and the 
Bayesian prior largely determines the outcome where the 
data are weak. Nevertheless it is interesting to note that the 
prevalence converges to the eventual asymptote at about 
half of the rate at which the prevalence rises at the start of 
the epidemic. 
 The peak value of the prevalence of infection (Figure 
4and Appendix Figure 11) varies substantially across the 
three groups of countries. In Nyanza Province, Homa Bay, 
Kisumu, Migori and Siaya, the average value of the peak 
prevalence was 40%, in Nairobi and Mombasa it was less 
than half of this at 18%, and in the rest of the country it was 
only 8%. This variation demands an explanation and has 
implications for how to roll out ART across the country. 
 The decline from the peak is consistent across the three 
groups of counties, Figure 12. In all three the prevalence 
falls to about 40% of its peak value but then stabilizes at 
lower steady state.  
 From these fits we obtain the weighted prevalence of 
infection in the three groups of counties (Figure 4). This 
shows clearly that the timing and initial rate of increase and 
the timing and the extent of the decline from the peak are 
similar in the three groups of counties but the peak occurred 
about one year earlier in Nairobi and Mombasa than in 
Nyanza Province. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The prevalence of HIV in different parts of Kenya. 
Blue: Nyanza Province; Red: Nairobi and Mombasa; Black: 
all of Kenya; Purple: all excluding the red and blue areas. 
Discussion 
The data and this analysis raises a number of important 
questions concerning the natural history of HIV in Kenya 
but the trend data are limited and not always consistent over 
time and the 2006 survey is particularly important as it 
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 5 
enables us to determine the absolute value of the prevalence 
with reasonable confidence in all counties. 
 The most important observation is the very high 
prevalence of infection in Nyanza Province even as 
compared to the immediately adjacent counties, especially 
Busia. It is known that the people of Nyanza Province do 
not carry out male circumcision by tradition and this is, of 
course, the reason why studies of male circumcision in 
Kenya have been carried out there.11 While it is clear that 
male circumcision reduces a man’s risk of infection by 
about 60% one might expect this to have a larger effect on 
the initial rate of increase than on the peak prevalence; the 
peak prevalence is more likely to be determined by the 
extent of heterogeneity in the risk of infection. In this 
regard, Busia County is of particular interest. Even though 
it borders both Lake Victoria and Uganda the prevalence in 
Busia (Figure 3) is less than half of the prevalence in the 
four counties of Nyanza (Figure 4). A careful comparison 
of Busia with Siaya, Kisumu, Homa Bay and Migori could 
yield important insights into the determinants of HIV in 
Kenya. 
 It has been suggested that labour migration is the reason 
why the nine countries, worst affected by HIV, are all in 
southern Africa.12-17 It is clear from the age distribution of 
men and women in Nairobi and Mombasa that there is 
considerable migration to both of these cities in people 
aged 15 to 25 years, with migration of women preceding 
that of men by about three years of age. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. The age and sex distribution of men (blue) and women 
(pink) in Nairobi and Mombasa in 2012. 
 It is perhaps not surprising that the prevalence of 
infection in Nairobi and Mombasa is about three times 
greater than in the rest of the country, excluding Nyanza 
Province. In this regard one should note that the main 
highway linking the outside world to Uganda starts in 
Mombasa, passes through Nairobi and Nakuru and then 
through Eldoret on the way to Kampala. The link to the 
epicentre of the HIV epidemic in East Africa and the 
movement of truck drivers and other migrant workers along 
this highway are both likely to be key determinants of the 
spread of HIV. It is also significant that the prevalence of 
infection in Nakuru, a major struck-stop 0n the Mombasa-
Kampala highway, is similar to the prevalence of infection 
in Nairobi and Mombasa and higher than in any other 
county apart from those in Nyanza Province. 
 From the fits to the prevalence data and the adult 
population of each county we estimate the number of 
people living with HIV in Kenya as shown in Table 1.  
Table 1. The number of people living with HIV, the total 
population, and the land area for Nyanza County, Nairobi 
and Mombasa. Numbers in brackets are percentages of the 
total. 
HIV (k) Pop. (M) Area (km)2
Total 1,363 24.4 582,650 
Nyanza 416 (31%) 2.5 (10%) 10,377 (1.8%)
Nairobi & Mombasa 242 (18%) 3.0 (12%) 649 (0.11%) 
Nyanza, Nairobi & Momb. 658 (48%) 4.7 (19%) 11,026 (1.9%)
 
 It seems likely that the epidemic of HIV in Kenya 
spread from Uganda along the Mombasa-Kampala 
highway. For reasons that are still not certain it then 
affected people living in Nyanza to a greater extent than 
people living elsewhere along the highway, and then spread 
out from the highway to people living in the rest of the 
country. 
 The immediate priority is to bring the epidemic under 
control in Nyanza Province which has 31% of all those 
living with HIV in Kenya but only includes 10% of the 
total population and 1.8% of the land area. Nairobi and 
Mombasa account for a further 18% of all those living with 
HIV in Kenya and although they make up 12% of the 
population they are concentrated in 0.11% of the land area. 
The logistics of delivering drugs and providing services to 
people living in such highly concentrated areas will be 
much simpler than providing services in the remaining 98% 
of the country. 
 Since Mombasa, Nairobi, Nakuru and Nyanza all lie 
along the Mombasa-Kampala highway this clearly 
facilitates the spread of HIV but also facilitates the 
provision of services. 
 It is very important that the other counties are not 
forgotten but the approach to the control of HIV in these 
counties will have to be different. First of all it is likely that 
controlling HIV in the high prevalence counties will have 
an indirect effect on the low prevalence counties. Second, 
to find people living in often remote and scattered areas 
might be more efficiently done through contact tracing, 
especially if people who migrate to Nairobi are identified 
and their local contacts tested for HIV. The logistics of 
delivering drugs to these remote places will remain a 
challenge. 
Conclusion 
Reaching the 90-90-90 UNAIDS target for HIV testing, 
ART treatment and levels of compliance will be 
challenging. However, those living in Nyanza Province are 
much more likely to be infected with HIV than people 
living elsewhere in Kenya and the geographical 
concentration of people living with HIV is much greater in 
Nairobi and Mombasa than anywhere else in Kenya. If the 
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 6 
90-90-90 targets can be reached first in Nyanza province 
and then in Nairobi and Mombasa with additional focus on 
the trucking route from Mombasa to Kampala, this alone 
should cover nearly half of all those living with HIV while 
only needing to access less than one-quarter of the whole 
population in a geographical area covering only 2% of the 
country. 
 Focussing initially on Nyanza Province, Nairobi and 
Mombasa will make universal testing, drug delivery and 
community support much easier and more effective. In 
other areas of the country the scattered nature of the 
population and the relatively low prevalence of infection 
will need other approaches. Where the prevalence of HIV 
and the density of people are both low, contact tracing 
becomes a more viable way of finding, testing, treating and 
providing support to people infected with HIV. 
 The initial rate of increase of the prevalence implies a 
doubling time of 1.7 years and a case reproduction number, 
R0, of 4.818 so that to eliminate HIV in Kenya will need an 
80% reduction in transmission. Reaching the 90-90-90 
target by 2020 will reduce R0 by 73% to a value of about 
1.3. If the roll-out of ART is supported by effective 
counselling and support, condom promotion, providing 
access to pre-exposure prophylaxis to people at high risk, 
especially to female sex workers, and the continued roll out 
of male circumcision, especially in Nyanza, this should 
easily provide the extra 30% reduction in transmission 
needed to bring R0 below 1 and ensure eventual elimination 
of the epidemic. 
 Because the initial rate of increase in the prevalence of 
HIV seems to be fairly consistent across the three key 
groups of countries, Nyanza, Nairobi and Mombasa, and 
the rest of Kenya, while the peak prevalence varies by a 
factor of five, it seems likely that the high rates of HIV in 
Nyanza as compared to the other counties reflects a greater 
heterogeneity in risk behaviour rather than a greater 
likelihood of individual risk per exposure. The reasons for 
these patterns of infection remain uncertain but should be 
explored further. 
 The next stage of this analysis will be to develop 
dynamical models of the epidemic in order to further test 
the ideas and suggestions discussed here but also to project 
future time trends in the epidemic, allowing for the current 
and future levels of ART coverage, and to carry out 
detailed cost benefit analyses which will be needed if the 
response is to be properly planned.  
. 
 
 
Appendix. Distributions of the fitted parameter values 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 ‘Scale’ is σ, the adjustment to the routine ANC data so that the fitted values passes through 
estimate from the 2006. 
 
 
 
 
 
 
 
 
 
 
Figure 7. ‘Half-rise’ is τ1 the time when the prevalence first reaches half its peak value. 
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Figure 8. ‘Half-fall’ is τ2 the time when the prevalence falls to half-way between the peak value and 
the eventual asymptotic value. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. ‘Rate of increase’ is ρ1 the initial rate of increase of the prevalence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. ‘Rate of decline’ is ρ2 the final rate of decline of the prevalence. 
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Figure 11. ‘Maximum’ is the peak value of the prevalence. 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. ‘Decline’ is the ratio of the prevalence in 2012 to the peak value of the prevalence. 
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